Dr. Mary Walton has been a PA for more than 20 years, working in addiction medicine integrating medical and behavioral health care. She has worked in clinical and academic medicine, administration, and has held leadership roles while serving as Associate Medical Director and Clinical Director for several organizations, including the Yale School of Medicine AIDS Program for almost fifteen years.
Dr. Walton has developed and established a variety of care platforms, including the first mobile buprenorphine clinic in the U.S.; syringe exchange and directly observed medication programs; a collaborative wrap-around medical/addiction/case management/housing program; mobile medical clinics; and buprenorphine treatment and ambulatory care in methadone clinics. In addition, she has written and secured various multimillion-dollar grants.
Dr. Walton has published peer-reviewed journal articles on topics such as telehealth counseling during COVID; buprenorphine; directly observed antiretroviral treatment in HIV-positive drug users; screening and delivery programs in mobile health care; and vaccinations at syringe exchange sites. She also co-authored a CDC’s Compendium of Evidence-Based HIV Behavioral Intervention.
Dr. Walton earned a bachelor’s degree from the University of South Florida in Mass Communications, a Master of Health Science from Quinnipiac University, and a Doctor of Medical Science from the University of Lynchburg. She lives in Rhode Island, where she surfs, snowboards, swims competitively, and enjoys laying in her hammock reading books and hanging out with her cat.